bluebird bio
BLUE
BLUE was delisted on the 30th of May, 2025.
177 hedge funds and large institutions have $1.9B invested in bluebird bio in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 68 increasing their positions, 61 reducing their positions, and 31 closing their positions.
11% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 61
11% more capital invested
Capital invested by funds: $1.71B → $1.9B (+$192M)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
10% less call options, than puts
Call options by funds: $22.4M | Put options by funds: $24.8M
5% less funds holding
Funds holding: 187 → 177 (-10)
26% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 31
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$38.2M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$26.9M |
| 3 |
State Street
Boston,
Massachusetts
|
+$21.8M |
| 4 |
TAM
Tiverton Asset Management
Wilimington,
Delaware
|
+$17.2M |
| 5 |
RI
RTW Investments
New York
|
+$16.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$17.6M |
| 2 |
Goldman Sachs
New York
|
-$11M |
| 3 |
TCIM
TIAA CREF Investment Management
New York
|
-$8.23M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6.65M |
| 5 |
CCI
Columbus Circle Investors
|
-$6.11M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
FMA
201
FNY Managed Accounts
New York
| – | -$85K | -154 | Closed |
|
202
Bank of Montreal
Toronto,
Ontario, Canada
| – | -$15K | -28 | Closed |
|
|
BFEC
203
Benjamin F. Edwards & Company
St. Louis,
Missouri
| – | -$9K | -15 | Closed |
|
|
PHK
204
Point72 Hong Kong
Hong Kong
| – | -$4K | -8 | Closed |
|
|
EFSCE
205
Enterprise Financial Services Corp (EFSC)
Clayton,
Missouri
| – | -$2K | -4 | Closed |
|
|
TDC
206
Thompson Davis & Co
Richmond,
Virginia
| – | -$1K | -3 | Closed |
|
207
US Bancorp
Minneapolis,
Minnesota
| – | -$2K | -3 | Closed |
|
BLUE Hedge Fund Activity: Q2 2016 in Review
177 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in bluebird bio (BLUE) for Q2 2016, worth a combined $1.9B — up 11% from $1.71B a quarter earlier.
Sellers outnumbered buyers: 31 funds closed out of BLUE and 23 opened new positions — a net loss of 8 holders — while 61 trimmed existing stakes and 68 added.
The largest buyer was Wellington Management Group, adding an estimated $38.2M. The largest seller was Capital World Investors, cutting an estimated $17.6M.
- 177 institutional investors held bluebird bio (BLUE) as of Q2 2016, down from 187 in Q1 2016.
- Funds reported $1.9B of bluebird bio stock for Q2 2016, up 11% quarter-over-quarter.
- 23 funds opened new bluebird bio positions in Q2 2016 and 31 closed out, a net change of -8 holders.
- The largest bluebird bio buyer in Q2 2016 was Wellington Management Group, an estimated $38.2M added.
- The largest bluebird bio seller in Q2 2016 was Capital World Investors, an estimated $17.6M sold.
Based on aggregated 13F filings for Q2 2016.